Defect of delta-sarcoglycan gene is responsible for development of dilated cardiomyopathy of a novel hamster strain, J2N-k: Calcineurin/PP2B activity in the heart of J2N-k hamster

Journal of Biochemistry

Volumn 134, Issue 2, 2003, Pages 269-276

  Mitsuhashi, Shinya ^a   Saito, Naohiro ^b   Watano, Keiko ^c,d   Igarashi, Keiichi ^e   Tagami, Seiichi ^f   Shima, Hiroshi ^a   Kikuchi, Kunimi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KOWA COMPANY LTD   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d National Hospital Organization Hakodate Hospital   (Japan)

^e Hokkaido Social Insurance Hospital   (Japan)

^f HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Calcineurin; Calcium influx; Delta sarcoglycan; Dilated cardiomyopathy; J2N k hamster; Protein phosphatase

Indexed keywords

CALCINEURIN; DELTA SARCOGLYCAN; NATRIURETIC FACTOR; SARCOGLYCAN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HAMSTER; HEART DILATATION; HEART MUSCLE CELL; IN VIVO STUDY; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; REGULATORY MECHANISM;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CALCINEURIN; CARDIOMYOPATHY, DILATED; CREATINE KINASE; CRICETINAE; CYTOSKELETAL PROTEINS; GENE DELETION; GENES; MEMBRANE GLYCOPROTEINS; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEDIGREE; RNA, MESSENGER; SARCOGLYCANS; TRANSCRIPTION, GENETIC; UP-REGULATION;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0141703293     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/jb/mvg140     Document Type: Article

References (40)

1. Dec, G.W. and Fuster, V. (1994) Idiopathic dilated cardiomyopathy. N. Engl. J. Med. 331, 1564-1575
2. Mestroni, L., Rocco, C., Vatta, M., Miocic, S., and Giacca, M. (1998) Advances in molecular genetics of dilated cardiomyopathy. The Heart Muscle Disease Study Group. Cardiol. Clin. 16, 611-621, vii
3. Badorff, C., Lee, G.H., Lamphear, B.J., Martone, M.E., Campbell, K.P., Rhoads, R.E., and Knowlton, K.U. (1999) Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat. Med. 5, 320-326
4. Luppi, P., Rudert, W.A., Zanone, M.M., Stassi, G., Trucco, G., Finegold, D., Boyle, G.J., Del Nido, P., McGowan, F.X. Jr., and Trucco, M. (1998) Idiopathic dilated cardiomyopathy: a superantigen-driven autoimmune disease. Circulation 98, 777-785
5. Olson, T.M., Michels, V.V., Thibodeau, S.N., Tai, Y.S., and Keating, M.T. (1998) Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280, 750-752
6. Coral-Vazquez, R., Cohn, R.D., Moore, S.A., Hill, J.A., Weiss, R.M., Davisson, R.L., Straub, V., Barresi, R., Bansal, D., Hrstka, R.F., Williamson, R., and Campbell, K.P. (1999) Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 98, 465-474
7. Sakamoto, A., Abe, M., and Masaki, T. (1999) Delineation of genomic deletion in cardiomyopathic hamster. FEBS Lett. 447, 124-128
8. Masutomo, K., Makino, N., Sugano, M., Miyamoto, S., Hata, T., and Yanaga, T. (1999) Extracellular matrix regulation in the development of Syrian cardiomyopathic Bio 14.6 and Bio 53.58 hamsters. J. Mol. Cell. Cardiol. 31, 1607-1615
9. Nigro, V., Okazaki, Y., Belsito, A., Piluso, G., Matsuda, Y., Politano, L., Nigro, G., Ventura, C., Abbondanza, C., Molinari, A.M., Acampora, D., Nishimura, M., Hayashizaki, Y., and Puca, G.A. (1997) Identification of the Syrian hamster cardiomyopathy gene. Hum. Mol. Genet. 6, 601-617
10. Melacini, P., Fanin, M., Duggan, D.J., Freda, M.P., Berardinelli, A., Danieli, G.A., Barchitta, A., Hoffman, E.P., Dalla Volta, S., and Angelini, C. (1999) Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve 22, 473-479
11. Saito, N., Iwai, T., Fujii, M., Kato, M., and Nagano, M. (1998) Establishment and its characterization of cardiomyopathic J-2-Nk hamsters and J-2-Nn non-myopathic hamsters. Shinkin no Kohzoh to Taisha 21, 125-133
12. Nagano, M. and Saito, N. (1998) in Zoku shinzou taisya jikken-hou. pp. 191-196
13. Olson, E.N. and Williams, R.S. (2000) Remodeling muscles with calcineurin. Bioessays 22, 510-519
14. Shimoyama, M., Hayashi, D., Takimoto, E., Zou, Y., Oka, T., Uozumi, H., Kudoh, S., Shibasaki, F., Yazaki, Y., Nagai, R., and Komuro, I. (1999) Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Circulation 100, 2449-2454
15. Eto, Y., Yonekura, K., Sonoda, M., Arai, N., Sata, M., Sugiura, S., Takenaka, K., Gualberto, A., Hixon, M.L., Wagner, M.W., and Aoyagi, T. (2000) Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training. Circulation 101, 2134-2137
16. Lim, H.W., De Windt, L.J., Steinberg, L., Taigen, T., Witt, S.A., Kimball, T.R., and Molkentin, J.D. (2000) Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy. Circulation 101, 2431-2437
17. Hayashida, W., Kihara, Y., Yasaka, A., and Sasayama, S. (2000) Cardiac calcineurin during transition from hypertrophy to heart failure in rats. Biochem. Biophys. Res. Commun. 273, 347-351
18. Wilkins, B.J. and Molkentin, J.D. (2002) Calcineurin and cardiac hypertrophy: where have we been? Where are we going? J. Physiol. 541, 1-8
19. Boelck, K., Muench, G., and Schwinger, R.H.G. (1999) Increased expressin of calcineurin in human failing compared to nonfailing myocardium. Circulation 100, 2677
20. Sussman, M.A., Lim, H.W., Gude, N., Taigen, T., Olson, E.N., Robbins, J., Colbert, M.C., Gualberto, A., Wieczorek, D.F., and Molkentin, J.D. (1998) Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 281, 1690-1693
21. Haq, S., Choukroun, G., Lim, H., Tymitz, K.M., del Monte, F., Gwathmey, J., Grazette, L., Michael, A., Hajjar, R., Force, T., and Molkentin, J.D. (2001) Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103, 670-677
22. Tsao, L., Neville, C., Musaro, A., McCullagh, K.J., and Rosenthal, N. (2000) Revisiting calcineurin and human heart failure. Nat. Med. 6, 2-3
23. Mitsuhashi, S., Shima, H., Kikuchi, K., Igarashi, K., Hatsuse, R., Maeda, K., Yazawa, M., Murayama, T., Okuma, Y., and Nomura, Y. (2000) Development of an assay method for activities of serine/threonine protein phosphatase type 2B (calcineurin) in crude extracts. Anal. Biochem. 278, 192-197
24. Megeney, L.A., Kablar, B., Perry, R.L., Ying, C., May, L., and Rudnicki, M.A. (1999) Severe cardiomyopathy in mice lacking dystrophin and MyoD. Proc. Natl Acad. Sci. USA 96, 220-225
25. Takeda, A., Kawai, S., Okada, R., Nagai, M., Takeda, N., and Nagano, M. (1993) Three-dimensional distribution of myocardial fibrosis in the new J-2-N cardiomyopathic hamster: comparison with electrocardiographic findings. Heart Vessels 8, 186-193
26. Urushibara, N., Karasaki, H., Nakamura, K., Mizuno, Y., Ogawa, K., and Kikuchi, K. (1998) The selective reduction in PTPdelta expression in hepatomas. Int. J. Oncol. 12, 603-607
27. Tamura, N., Ogawa, Y., Itoh, H., Arai, H., Suga, S., Nakagawa, O., Komatsu, Y., Kishimoto, I., Takaya, K., Yoshimasa, T., and et al. (1994) Molecular cloning of hamster brain and atrial natriuretic peptide cDNAs. Cardiomyopathic hamsters are useful models for brain and atrial natriuretic peptides. J. Clin. Invest. 94, 1059-1068
28. Chang, C.D., Mukai, H., Kuno, T., and Tanaka, C. (1994) cDNA cloning of an alternatively spliced isoform of the regulatory subunit of Ca2+/calmodulin-dependent protein phosphatase (calcineurin B alpha 2). Biochim. Biophys Acta 1217, 174-180
29. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
30. Takagi, C., Urasawa, K., Yoshida, I., Takagi, Y., Kaneta, S., Nakano, N., Onozuka, H., and Kitabatake, A. (1999) Enhanced GRK5 expression in the hearts of cardiomyopathic hamsters, J2N-k. Biochem. Biophys. Res. Commun. 262, 206-210
31. Passier, R., Zeng, H., Frey, N., Naya, F.J., Nicol, R.L., McKinsey, T.A., Overbeek, P., Richardson, J.A., Grant, S.R., and Olson, E.N. (2000) CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105, 1395-1406
32. Zhu, W., Zou, Y., Shiojima, I., Kudoh, S., Aikawa, R., Hayashi, D., Mizukami, M., Toko, H., Shibasaki, F., Yazaki, Y., Nagai, R., and Komuro, I. (2000) Ca2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy. J. Biol. Chem. 275, 15239-15245
33. Nonaka, I. (1998) Animal models of muscular dystrophies. Lab. Anim. Sci 48, 8-17
34. Baudet, S. (2000) Hypertrophy and dilation: a TOTally new story? Cardiovasc. Res. 46, 17-19
35. Kawaguchi, H., Shoki, M., Sano, H., Kudo, T., Sawa, H., Okamoto, H., Sakata, Y., and Yasuda, H. (1991) Phospholipid metabolism in cardiomyopathic hamster heart cells. Circ. Res. 69, 1015-1021
36. Balke, C.W. and Shorofsky, S.R. (1998) Alterations in calcium handling in cardiac hypertrophy and heart failure. Cardiovasc. Res. 37, 290-299
37. Solaro, R.J. (1999) Is calcium the 'cure' for dilated cardiomyopathy? Nat. Med. 5, 1353-1354
38. Nakamura, T.Y., Iwata, Y., Sampaolesi, M., Hanada, H., Saito, N., Artman, M., Coetzee, W.A., and Shigekawa, M. (2001) Stretch-activated cation channels in skeletal muscle myotubes from sarcoglycan-deficient hamsters. Amer. J. Physiol. Cell. Physiol. 281, C690-699
39. Taigen, T., De Windt, L.J., Lim, H.W., and Molkentin, J.D. (2000) Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc. Natl Acad. Sci. USA 97, 1196-1201
40. Sussman, M.A., Welch, S., Walker, A., Klevitsky, R., Hewett, T.E., Witt, S.A., Kimball, T.R., Price, R., Lim, H.W., and Molkentin, J.D. (2000) Hypertrophic defect unmasked by calcineurin expression in asymptomatic tropomodulin overexpressing transgenic mice. Cardiovasc. Res. 46, 90-101